ANVS Shares Outstanding History
Below is a table of the ANVS shares outstanding history going back to 11/1/2021:

Date ANVS Shares Outstanding
11/1/20218.10M
2/28/20228.16M
5/2/20228.16M

Also see: ANVS Market Cap History
ANVS YTD Return
ANVS Historical Shares Outstanding:
+1.57% CAGR
ANVS Historical Shares Outstanding: +1.57% CAGR

Mouse over chart for data details
11/1/2021 ...5/2/2022
Annovis Bio is a clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease (AD), Parkinson's disease (PD) and Alzheimer's disease in Down syndrome (AD-DS). Co.'s pipeline consists of: ANVS401, which is an orally administered drug being developed for chronic indications such as AD, PD and AD-DS by inhibiting the overproduction of neurotoxic proteins that kill nerve cells; ANVS405, which is focused on protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which increases cognitive capability in later stages of AD and dementia. We show 3 historical shares outstanding datapoints in our coverage of ANVS's shares outstanding history.

Understanding the changing numbers of ANVS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ANVS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ANVS by allowing them to research ANVS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ANVS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Annovis Bio (ANVS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

AORT Shares Outstanding History
APDN Shares Outstanding History
APEN Shares Outstanding History
APLS Shares Outstanding History
APLT Shares Outstanding History
APR Shares Outstanding History
APRE Shares Outstanding History
APRI Shares Outstanding History
APTX Shares Outstanding History
APVO Shares Outstanding History
More Healthcare companies »

 

ANVS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.